Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "European Radiology"
DOI: 10.1007/s00330-019-06121-y
Abstract: ObjectiveTo evaluate the impact of anterior tumor location on oncologic efficacy, complication rates, and procedure duration for 151 consecutive biopsy-proven clinical T1a renal cell carcinoma (RCC) treated with percutaneous microwave (MW) ablation.MethodsThis single-center retrospective study… read more here.
Keywords: tumor location; percutaneous microwave; ablation; microwave ablation ... See more keywords
Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.
Sign Up to like & getrecommendations! Published in 2019 at "Urology"
DOI: 10.1016/j.urology.2019.06.029
Abstract: OBJECTIVES To evaluate contemporary trends in the management of SRMs and how patient age has impacted practice patterns METHODS: Using the NCDB PUF from 2002-2015, we identified patients with T1a renal masses. The initial treatment… read more here.
Keywords: age; ablation; treatment; ablation surveillance ... See more keywords
Radiofrequency ablation of pathologically proven T1a renal tumors: 15 years follow up—A tertiary cancer center experience.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.4582
Abstract: 4582Background: To evaluate the long term oncologic efficacy and overall survival of radiofrequency ablation (RFA) for pathologically proven T1a Renal cell carcinoma (RCC). Methods: we retrospectively reviewed our renal ablation data base between January 2001… read more here.
Keywords: ablation; proven t1a; pathologically proven; t1a renal ... See more keywords